Cancer Causes & Control

, Volume 8, Issue 3, pp 406–419 | Cite as

Organic solvents and cancer

  • Elsebeth Lynge
  • Ahti Anttila
  • Kari Hemminki


Epidemiologic evidence on the relationship between organic solvents and cancer is reviewed. In the 1980s, more than a million persons were potentially exposed to some specific solvents in the United States; in Canada, 40 percent of male cancer patients in Montreal had experienced exposure to solvents; in the Finnish population, one percent was regularly exposed. There is evidence for increased risks of cancer following exposure to: trichloroethylene (for the liver and biliary tract and for non-Hodgkin's lymphomas); tetrachloroethylene (for the esophagus and cervix - although confounding by smoking, alcohol, and sexual habits cannot be excluded - and non-Hodgkin's lymphoma); and carbon tetrachloride (lymphohematopoietic malignancies). An excess risk of liver and biliary tract cancers was suggested in the cohort with the high exposure to methylene chloride, but not found in the other cohorts where an excess risk of pancreatic cancer was suggested. 1,1,1-trichloroethane has been used widely, but only a few studies have been done suggesting a risk of multiple myeloma. A causal association between exposure to benzene and an increased risk of leukemia is well-established, as well as a suggested risk of lung and nasopharynx cancer in a Chinese cohort. Increased risks of various gastrointestinal cancers have been suggested following exposure to toluene. Two informative studies indicated an increased risk of lung cancer, not supported by other studies. Increased risks of lymphohematopoietic malignancies have been reported in some studies of persons exposed to toluene or xylene, but not in the two most informative studies on toluene. Occupation as a painter has consistently been associated with a 40 percent increased risk of lung cancer. (With the mixed exposures, however, it is not possible to identify the specific causative agent[s].) A large number of studies of workers exposed to styrene have evidenced no consistent excess risk of all lymphohematopoietic malignancies, although the most sensitive study suggested an excess risk of leukemia among workers with a high exposure.

Malignant neoplasms organic solvents 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    United States National Institute for Occupational Safety and Health. National Occupational Exposure Survey 1981–83. Cincinnati, OH (USA): NIOSH, 1994.Google Scholar
  2. 2.
    Siemiatycki J, ed. Risk Factors for Cancer in the Workplace. Boca Raton, FL (USA): CRC Press, 1991: 1–325.Google Scholar
  3. 3.
    Anttila A, Sallmén M, Hemminki K. Carcinogenic chemi-cals in the occupational environment. Pharmacol Toxicol 1993; 72: 69–76.Google Scholar
  4. 4.
    Jensen AA, Breum N, Backer J, Lynge E. Occupational exposure to styrene in Denmark 1955–88. Am J Ind Med1990; 17: 593-606.Google Scholar
  5. 5.
    International Agency for Research on Cancer. Overall Evaluations of Carcinogenicity: An Updating of IARCMonographs Volumes 1–42. Lyon, France: IARC, 1987; IARC Monogr Eval Carcinog Risks Humans, Suppl. No. 7.Google Scholar
  6. 6.
    International Agency for Research on Cancer. Dry Clean-ing, Some Chlorinated Solvents and Other Industrial Chemicals. Lyon, France: IARC, 1995; IARC Monogr Eval Carcinog Risk Humans, Vol. 63.Google Scholar
  7. 7.
    International Programme on Chemical Safety. Environ-mental Health Criteria. 136 1,1,1-Trichloroethane. Geneva, Switzerland: World Health Organization, 1992.Google Scholar
  8. 8.
    International Agency for Research on Cancer. Some Indus-trial Chemicals. Lyon, France: IARC, 1994; IARC Monogr Eval Carcinog Risk Humans, Vol. 60.Google Scholar
  9. 9.
    International Agency for Research on Cancer. Some Organic Solvents, Resin Monomers and Related Compounds, Pig-ments and Occupational Exposures in Paint Manufacture and Painting. Lyon, France: IARC, 1989; IARC Monogr Eval Carcinog Risks Humans, Vol. 47.Google Scholar
  10. 10.
    Weiss N. Cancer in relation to occupational exposure to trichloroethylene. Occup Environ Med 1996; 53: 1–5.Google Scholar
  11. 11.
    Axelson O, Seldén A, Andersson K, Hogstedt C. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J Occup Med 1994; 36: 556–62.Google Scholar
  12. 12.
    Anttila A, Pukkala E, Sallmén M, Hernberg S, Hemminki K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med 1995; 37: 797–806. (1995a)Google Scholar
  13. 13.
    Anttila A, Riala R, Pukkala E, Sallmén M, Hernberg S, Hemminki K. Occupational Exposure to Solvents and Cancer Incidence. Helsinki, Finland: Finnish Institute of Occupational Health, 1995: 1–74 (in Finnish).[Työnteki-jjöiden liuotinaltistuminen ja syöpäsairaudet. Työterveyslaitos, Helsinki 1995: 1-74.] (1995b)Google Scholar
  14. 14.
    Steward PA, Lee JS, Marano DE, Spirtas R, Forbes CD, Blair A. Retrospective cohort mortality study of workers at an aircraft maintenance facility. II. Exposures and their assessment. Br J Ind Med 1991; 48: 531–7.Google Scholar
  15. 15.
    Spirtas R, Stewart PA, Lee JS, et al. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. Br J Ind Med 1991; 48: 515–30.Google Scholar
  16. 16.
    Wong O, Morgan R. Final Report: Historical Prospective Mortality Study of Hughes Aircraft Employees at Air Force Plant No 44. Alameda, CA (USA): ENSR Health Sciences, 1990.Google Scholar
  17. 17.
    Garabrant DH, Held J, Langholz B, Bernstein L. Mortality of aircraft manufacturing workers in southern California. Am J Ind Med 1988; 13: 683–93.Google Scholar
  18. 18.
    Henschler D, Vamvakas S, Lammert M, et al. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethene. Arch Toxicol 1995; 69: 291–9.Google Scholar
  19. 19.
    Novotná E, David A, Málek B. An epidemiological study on hepatic tumour incidence in subjects working with trichloroethylene [in Czech]. Prac Lék 1979; 31: 121–3.Google Scholar
  20. 20.
    Blair A, Mason TJ. Cancer mortality in United States coun-ties with metal electroplating industries. Arch Environ Health 1980; 35: 92–4.Google Scholar
  21. 21.
    Paddle GM. Incidence of liver cancer and trichloroethylene manufacture: joint study by industry and a cancer registry. Br Med J 1983; 286: 846.Google Scholar
  22. 22.
    Shindell S, Ulrich S. A cohort study of employees of a manufacturing plant using trichloroethylene. J Occup Med1985; 27: 577–9.Google Scholar
  23. 23.
    Dubrow R, Gute DM. Cause-specific mortality among Rhode Island jewelry workers. Am J Ind Med 1987; 12: 579–93.Google Scholar
  24. 24.
    Hernberg S, Korkala ML, Asikainen U, Riala R. Primary liver cancer and exposure to solvents. Int Arch Occup Environ Health 1984; 54: 147–53.Google Scholar
  25. 25.
    Hernberg S, Kauppinen T, Riala R, Korkala ML, Asikainen U. Increased risk for primary liver cancer among women exposed to solvents. Scand J Work Environ Health 1988; 14: 356–65.Google Scholar
  26. 26.
    Hardell L, Bengtsson NO, Jonsson U, Eriksson S, Larsson LG. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute inter-mittent porphyria - an epidemiological investigation. Br J Organic solvents Cancer Causes and Control. Vol 8. 1997 417. Cancer 1984; 50: 389–97.Google Scholar
  27. 27.
    Hardell L, Eriksson M, Lenner P, Lundgren E. Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-control study. Br J Cancer 1981; 43: 169–76.Google Scholar
  28. 28.
    Weiss N. Cancer in relation to occupational exposure to perchloroethylene. Cancer Causes Control 1995; 6: 257–66.Google Scholar
  29. 29.
    Ruder AM, Ward EM, Brown DP. Cancer mortality in female and male dry-cleaning workers. J Occup Med 1994; 36: 867–74.Google Scholar
  30. 30.
    Blair A, Stewart PA, Tolbert PE, et al. Cancer and other causes of death among a cohort of dry cleaners. Br J Ind Med 1990; 47: 162–8.Google Scholar
  31. 31.
    Olsen GW, Hearn S, Cook RR, Currier MF, Allen S. Mor-tality experience of a cohort of Louisiana chemical workers. J Occup Med 1989; 31: 32–4.Google Scholar
  32. 32.
    Wilcosky TC, Checkoway H, Marshall EG, Tyroler HA. Cancer mortality and solvent exposures in the rubber industry. Am Ind Hyg Assoc J 1984; 45: 809–11.Google Scholar
  33. 33.
    Pippard EC, Acheson ED. The mortality of boot and shoe makers, with special reference to cancer. Scand J Work Environ Health 1985; 11: 249–55.Google Scholar
  34. 34.
    Ott MG, Carlo GL, Steinberg S, Bond GG. Mortality among employees engaged in chemical manufacturing and related activities. Am J Epidemiol 1985; 122: 311–22.Google Scholar
  35. 35.
    Hearne FT, Pifer JW, Grose F. Absence of adverse mortality effects in workers exposed to methylene chloride: an update. J Occup Med 1990; 32: 234–40.Google Scholar
  36. 36.
    Lanes SF, Rothman KJ, Dreyer NA, Soden KJ. Mortality update of cellulose fiber production workers. Scand J Work Environ Health 1993; 19: 426–8.Google Scholar
  37. 37.
    Shannon HS, Haines T, Bernholz C, et al. Cancer morbidity in lamp manufacturing workers. Am J Ind Med 1988; 14: 281–90.Google Scholar
  38. 38.
    Cragle DL, Wells SM, Tankersley WG. An occupational morbidity study of a population potentially exposed to epoxy resins, hardeners, and solvents. Appl Occup Environ Hyg 1992; 7: 826–34.Google Scholar
  39. 39.
    Sinks T, Lushniak B, Haussler BJ, et al. Renal cell cancer among paperboard printing workers. Epidemiology 1992; 3: 483–9.Google Scholar
  40. 40.
    International Agency for Research on Cancer. Chlorinated Drinking Water, Chlorination By-products, Some Other Halogenated Compounds, Cobalt and Cobalt Compounds. Lyon, France: IARC, 1991; IARC Monogr Eval Carcinog Risks Humans, Vol. 52.Google Scholar
  41. 41.
    Morris RD, Audet A-M, Angelillo IF, Chalmers TC, Mosteller F. Chlorination, chlorination by-products, and cancer: A meta-analysis. Am J Public Health 1992; 82: 955–63.Google Scholar
  42. 42.
    International Agency for Research on Cancer. Some Industrial Chemicals and Dyestuffs. Lyon, France: IARC, 1982; IARC Monogr Eval Carcinog Risks Humans, Vol. 29.Google Scholar
  43. 43.
    Paxton MB, Chinchilli VM, Brett SM, Rodricks JV. Leu-kemia risk associated with benzene exposure in the Pliofilm cohort: I. Mortality update and exposure distribution. Risk Analysis 1994; 14: 147–54.Google Scholar
  44. 44.
    Wong O. Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. Occup Environ Med 1995; 52: 380–4.Google Scholar
  45. 45.
    Yin SN, Hayes RB, Linet MS, Li GL, et al. A cohort study of cancer among benzene exposed workers in China: Over-all results. Am J Ind Med 1996; 29: 227–35.Google Scholar
  46. 46.
    European Union. Council Directive 85/210/EEC of 20 March 1985 on the harmonization of legislation on lead content in gasoline.Google Scholar
  47. 47.
    Rinsky RA, Smith AB, Hornung R, et al. Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med1987; 316: 1044–50.Google Scholar
  48. 48.
    Paxton MB, Chinchilli VM, Brett SM, Rodricks JV. Leu-kemia risk associated with benzene exposure in the Pliofilm cohort. II. Risk estimates. Risk Anal 1994; 14: 155–61.Google Scholar
  49. 49.
    International Agency for Research on Cancer. Wood, Leather and Some Associated Industries. Lyon, France: IARC, 1981; IARC Monogr Eval Carcinog Risks Humans,Vol. 2 5.Google Scholar
  50. 50.
    McMichael AJ, Spirtas R, Kupper LL, Gamble JF. Solvent exposure and leukemia among rubber workers: an epidemiologic study. J Occup Med 1975; 17: 234–9.Google Scholar
  51. 51.
    Greene MH, Hoover RN, Eck RL, Fraumeni JF Jr. Cancer mortality among printing plant workers. Environ Res 1979; 20: 66–73.Google Scholar
  52. 52.
    Thomas TL, Waxweiler RJ. Brain tumors and occupational risk factors. Scand J Work Environ Health 1986; 12: 1–15.Google Scholar
  53. 53.
    Wong O. A cohort mortality study of employees exposed to chlorinated chemicals. Am J Ind Med 1988; 14: 417–31.Google Scholar
  54. 54.
    Partanen T, Heikkilä P, Hernberg S, Kauppinen T, Moneta G, Ojajärvi A. Renal cell cancer and occupational exposure to chemical agents. Scand J Work Environ Health 1991; 17: 231–9.Google Scholar
  55. 55.
    Lagorio S, Forastiere F, Iavarone I, Vanacore N, Fuselli S, Carere A. Exposure assessment in a historical cohort of filling station attendants. Int J Epidemiol 1993; 22(Suppl 2): S51–6.Google Scholar
  56. 56.
    Miller BA, Blair A, Reed EJ. Extended mortality follow-up among men and women in a U.S. furniture workers union. Am J Ind Med 1994; 25: 537–49.Google Scholar
  57. 57.
    Kauppinen T, Partanen T, Degerth R, Ojajärvi A. Pancreatic cancer and occupational exposures. Epidemiology 1995; 6: 498–502.Google Scholar
  58. 58.
    Chen R, Seaton A. A meta-analysis of mortality among workers exposed to organic solvents. Occup Med 1996; 46: 337–44.Google Scholar
  59. 59.
    Woods JS, Polissar L, Severson RK, Heuser LS, Kulander BG. Soft tissue sarcoma and non-Hodgkin's lymphoma in relation to phenoxyherbicide and chlorinated phenol exposure in Western Washington. JNCI 1987; 78: 899–910.Google Scholar
  60. 60.
    Olsson H, Brandt L. Risk of non-Hodgkin's lymphoma among men occupationally exposed to organic solvents. Scand J Work Environ Health 1988; 14: 246–51.Google Scholar
  61. 61.
    Persson B, Dahlander AM, Fredriksson M, Noorlind Brage H, Ohlson CG, Axelson O. Malignant lymphomas and occupational exposures. Br J Ind Med 1989; 46: 516–20.Google Scholar
  62. 62.
    Scherr PA, Hutchison GB, Neiman RS. Non-Hodgkin's lymphoma and occupational exposure. Cancer Res 1992; 52(Suppl): 5503s-9s.Google Scholar
  63. 63.
    Persson B, Fredriksson M, Olsen K, Boeryd B, Axelson O. Some occupational exposure as risk factors for malignant lymphomes. Cancer 1993; 72: 1773–8.Google Scholar
  64. 64.
    La Vecchia C, Negri E, D'Avenzo B, Franceschi S. Occu-pation and lymphoid neoplasms. Br J Cancer 1989; 60: 385–8.Google Scholar
  65. 65.
    D'Amore F, Hasle H, Hansen KS. Occupational exposures and non-Hodgkin's lymphoma. Hematol Rev 1992; 6: 183–99.Google Scholar
  66. 66.
    Olsson H, Brandt L. Occupational exposure to organic solvents and Hodgkin's disease in men. Scand J Work Environ Health 1980; 6: 302–5.Google Scholar
  67. 67.
    Flodin U, Andersson L, Anjou CG, Palm UB, Vikrot O, Axelson O. A case-referent study on acute myeloid leuke-mia, background radiation and exposure to solvents and other agents. Scand J Work Environ Health 1981; 7: 169–78.Google Scholar
  68. 68.
    Svensson BG, Nise G, Englander V, Attewell R, Skerfving S, Möller T. Deaths and tumours among rotogravure print-ers exposed to toluene. Br J Ind Med 1990; 47: 372–9.Google Scholar
  69. 69.
    Walker JT, Bloom TF, Stern F, Okun AH, Fingerhut MA, Halperin WE. Mortality of workers employed in shoe manufacturing. Scand J Work Environ Health 1993; 19: 89–95.Google Scholar
  70. 70.
    Carpenter AV, Flanders WD, Frome EL, Tankersley WG, Fry SA. Chemical exposures and central nervous system cancers: A case-control study among workers at two nuclear facilities. Am J Ind Med 1988; 13: 351–62.Google Scholar
  71. 71.
    Berlin K, Edling C, Persson B, et al. Cancer incidence and mortality of patients with suspected solvent-related disor-ders. Scand J Work Environ Health 1995; 21: 362–7.Google Scholar
  72. 72.
    Miller BA, Silverman DT, Hoover RN, Blair A. Cancer risk among artistic painters. Am J Ind Med 1986; 9: 281–7.Google Scholar
  73. 73.
    Gubéran E, Usel M, Raymond L, Tissot R, Sweetnam PM. Disability, mortality, and incidence of cancer among Geneva painters and electricians: a historical prospective study. Br J Ind Med 1989; 46: 16–23.Google Scholar
  74. 74.
    Bethwaite PB, Pearce N, Fraser J. Cancer risks in painters: study based on the New Zealand Cancer Registry. Br J Ind Med 1990; 47: 742–6.Google Scholar
  75. 75.
    Skov T, Weiner J, Pukkala E, Malker H, Andersen A, Lynge E. Risk for cancer of the pharynx and oral cavity among male painters in the Nordic countries. Arch Environ Health1993; 48: 176–80.Google Scholar
  76. 76.
    Pukkala E. Cancer Risk by Social Class and Occupation. A Survey of 109,000 Cancer Cases among Finns of Working Age. Contributions to Epidemiology and Biostatistics. Basel, Switzerland: Karger, 1995: Vol. 7.Google Scholar
  77. 77.
    Terstegge CW, Swaen GM, Slangen JJ, van Vliet C. Mor-tality patterns among commercial painters in the Netherlands. Occup Environ Health 1995; 1: 303–10.Google Scholar
  78. 78.
    Lindquist R, Nilsson B, Eklund G, Gahrton G. Increased risk of developing acute leukemia after employment as a painter. Cancer 1987; 60: 1378–84.Google Scholar
  79. 79.
    McMichael AJ, Spirtas R, Gamble JF, Tousey PM. Mortality among rubber workers: relationship to specific jobs. J Occup Med 1976; 18: 178–85.Google Scholar
  80. 80.
    Meinhardt TJ, Lemen RA, Crandall MS, Young RJ. Envi-ronmental epidemiologic investigation of the styrene-butadiene rubber industry. Scand J Work Environ Health1982; 8: 250–9.Google Scholar
  81. 81.
    Matanoski GM, Santos-Burgoa C, Schwartz L. Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943–1982). Environ Health Per-spect1990; 86: 107-17.Google Scholar
  82. 82.
    Bond GG, Bodner KM, Olsen GW, Cook RR. Mortality among workers engaged in the development or manufacture of styrene-based products - an update. Scand J Work Environ Health 1992; 18: 145–54.Google Scholar
  83. 83.
    Nicholson WJ, Selikoff IJ, Seidman H. Mortality experience of styrene-polystyrene polymerization workers. Scand J Work Environ Health 1978; 4(Suppl 2): 247–52.Google Scholar
  84. 84.
    Hodgson JT, Jones RD. Mortality of styrene production, polymerization and processing workers at a site in north-west England. Scand J Work Environ Health 1985, 11: 347–52.Google Scholar
  85. 85.
    Okun AH, Beaumont JJ, Meinhardt TJ, Crandall MS. Mor-tality patterns among styrene-exposed boatbuilders. Am J Ind Med 1985; 8: 193–205.Google Scholar
  86. 86.
    Coggon D, Osmond C, Pannett B, Simmonds S, Winter PD, Acheson ED. Mortality of workers exposed to styrene in the manufacture of glass-reinforced plastics. Scand J Work Environ Health 1987; 13: 94–9.Google Scholar
  87. 87.
    Wong O, Trent LS, Whorton MD. An updated cohort mortality study of workers exposed to styrene in the reinforced plastics and composites industry. Occup Environ Med 1994; 51: 386–96.Google Scholar
  88. 88.
    Kogevinas M, Ferro G, Andersen AA, et al. Cancer mor-tality in a historical cohort study of workers exposed to styrene. Scand J Work Environ Health 1994; 20: 251–61.Google Scholar
  89. 89.
    Kolstad HA, Lynge E, Olsen J, Breum N. Incidence of lymphohematopoietic malignancies among styrene-exposed workers of the reinforced plastics industry. Scand J Work Environ Health 1994; 20: 272–8.Google Scholar
  90. 90.
    Kolstad HA, Juel K, Olsen J, Lynge E. Exposure to styrene and chronic health effects: mortality and incidence of solid cancers in the Danish reinforced plastics industry. Occup Environ Med 1995; 52: 320–7.Google Scholar
  91. 91.
    Kolstad HA. Styrene and Chronic Diseases [in Danish]. Århus, Denmark: Institut for Epidemiologi og Social-medicin, Kræftens Bekæmpelse, 1995; Rapport nr. 13. Organic solvents Cancer Causes and Control. Vol 8. 1997 419 Google Scholar

Copyright information

© Chapman and Hall 1997

Authors and Affiliations

  • Elsebeth Lynge
    • 1
  • Ahti Anttila
    • 2
  • Kari Hemminki
    • 3
  1. 1.Danish Cancer SocietyKøbenhavnDenmark
  2. 2.Finnish Institute of Occupational HealthHelsinkiFinland
  3. 3.Center for Nutrition and ToxicologyKarolinska InstituteHuddingeSweden

Personalised recommendations